Veru Inc (NASDAQ:VERU) is set to release its Q2 2025 earnings on May 8, 2025. The consensus estimate for Q2 2025 revenue is $0.58 million, and the earnings are expected to come in at -$0.06 per share.
Veru Inc (NASDAQ:VERU) is set to release its Q3 2025 earnings on Aug 12, 2025. The consensus estimate for Q3 2025 revenue is $0.65 million, and the earnings are expected to come in at -$0.05 per share ...
Veru and its shareholders had high hopes for sabizabulin, an orally administered COVID treatment. These hopes were diminished greatly on Wednesday, when a Food and Drug Administration (FDA) advisory ...
Insiders were net buyers of Veru Inc.'s (NASDAQ:VERU ) stock during the past year. That is, insiders bought more stock than they sold. While we would never suggest that investors should base their ...
MIAMI - Veru Inc. (NASDAQ:VERU), a clinical-stage biopharmaceutical company whose stock has declined over 22% in the past week according to InvestingPro data, has selected a novel modified release ...